Consequently, it is plausible that the virus can elicit an augmented secretion of TGF-β, either directly or indirectly, by activating periostin in fibroblasts and basal keratinocytes during both the acute and protracted phases of COVID-19 [32,75]. The gene discussed is TGFB1; the disease is COVID-19.